Literature DB >> 1355372

The type 1 (EGFR-related) family of growth factor receptors and their ligands.

S A Prigent1, N R Lemoine.   

Abstract

This review considers the biology of the type 1 growth factor receptor family which is increasingly recognised as important in the control of normal cell proliferation and in the pathogenesis of human cancer. The family currently comprises three closely related members: the epidermal growth factor (EGF) receptor, c-erbB-2 and c-erbB-3, all of which show abnormalities of expression in various human tumours. The family of factors related to EGF has also expanded recently and now includes transforming growth factor alpha, heparin-binding EGF, amphiregulin, cripto and heregulin, as well as several other potential ligands for the c-erbB2-2 receptor. The involvement of these receptors and growth factors in human cancer has implications for the design of novel forms of therapy for cancer, and we review recent advances and future avenues for investigation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355372     DOI: 10.1016/0955-2235(92)90002-y

Source DB:  PubMed          Journal:  Prog Growth Factor Res        ISSN: 0955-2235


  53 in total

1.  Correlation between the Concentration of c-erbB-2 Protein, EGF-receptor and TGF alpha in Breast Cancer Tissue, and Clinicopathological Parameters.

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

Review 2.  Roles of transforming growth factor-alpha and related molecules in the nervous system.

Authors:  C J Xian; X F Zhou
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

Review 3.  Growth factors in the gastrointestinal tract.

Authors:  N R Lemoine; H Y Leung; W J Gullick
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

4.  The linear C-terminal regions of epidermal growth factor (EGF) and transforming growth factor-alpha bind to different epitopes on the human EGF receptor.

Authors:  A E Lenferink; A D De Roos; M J Van Vugt; M L Van de Poll; E J Van Zoelen
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

5.  The interaction of the ErbB4 intracellular domain p80 with α-enolase in the nuclei is associated with the inhibition of the neuregulin1-dependent cell proliferation.

Authors:  Satomi Yamada; Masaki Marutsuka; Miyabi Inoue; Jidong Zhang; Shin-Ichi Abe; Ken-Ichi Ishibashi; Naoto Yamaguchi; Ko Eto
Journal:  Int J Biochem Mol Biol       Date:  2014-05-15

6.  Contractile and cytoskeletal proteins in urinary bladder smooth muscle from rats treated with epidermal growth factor.

Authors:  L Vinte-Jensen; B Uvelius; E Nexø; A Arner
Journal:  Urol Res       Date:  1996

Review 7.  The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck.

Authors:  Ranee Mehra; Roger B Cohen; Barbara A Burtness
Journal:  Clin Adv Hematol Oncol       Date:  2008-10

8.  Co-expression of cox-2, C-met and beta-catenin in cells forming invasive front of gallbladder cancer.

Authors:  Woo Sung Moon; Ho Sung Park; Ho Lee; Rama Pai; Andrzej S Tarnawski; Kyung Ryoul Kim; Kyu Yun Jang
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

9.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.

Authors:  E Tzahar; H Waterman; X Chen; G Levkowitz; D Karunagaran; S Lavi; B J Ratzkin; Y Yarden
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Biomechanical properties of ileum after systemic treatment with epithelial growth factor.

Authors:  Jian Yang; Jing-Bo Zhao; Yan-Jun Zeng; Hans Gregersen
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.